Artrya hits over 3-week high on first commercial agreement in Australia
02/04/2024 01:34
** Shares of Artrya AYA.AX rise as much as 8.5% to A$0.32,
their highest since March 7
** Medical technology co enters its first commercial
agreement in Australia with Cardiac Centre NSW and Cardiac CT
Centre NSW
** Says agreement to use co's Salix Coronary Anatomy
software for the diagnosis of cardiovascular disease
** About 278,300 shares change hands, compared with the
30-day average volume of 55,300 shares
** Stock up 33.3% this year, as of last close
(Reporting by Megha Rani)
((Megha.Rani2@thomsonreuters.com;))